Intellia Therapeutics Inc

NASDAQ:NTLA   10:44:25 AM EDT
45.64
+1.83 (+4.18%)
Earnings Announcements

Intellia Therapeutics Inc - Q1 2022 Collaboration Revenue Increased By $4.8 Million To $11.3 Million

Published: 05/05/2022 11:48 GMT
Intellia Therapeutics Inc (NTLA) - Collaboration Revenue Increased by Approximately $4.8 Million to $11.3 Million During the First Quarter of 2022.
Qtrly Loss per Share $1.96.
Q1 Earnings per Share View $-1.11, Revenue View $8.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $9.41 Million
Adjusted EPS is expected to be -$1.30

Next Quarter Revenue Guidance is expected to be $9.84 Million
Next Quarter EPS Guidance is expected to be -$1.31

More details on our Analysts Page.